Tips from Other Journals
Elevated C-Reactive Protein and Risk of Hypertension
Am Fam Physician. 2004 Jun 15;69(12):2924.
The C-reactive protein level is an indicator of systemic inflammation that is associated with an increased risk of stroke and myocardial infarction. C-reactive protein, perhaps mediated through inflammatory factors, is elevated in patients with higher blood pressures. Sesso and colleagues conducted a study to determine whether normotensive patients with elevated C-reactive protein levels had an increased risk of developing hypertension.
Baseline blood samples were collected from participants in the Women’s Health Study and assayed for C-reactive protein. Eligible participants were healthy women without a history of hypertension. Incident cases of hypertension were identified on follow-up questionnaires.
During a median follow-up of 7.8 years, 5,365 of 20,525 women developed hypertension. There was an overall positive association between increasing levels of C-reactive protein and the risk of developing hypertension. Patients with the highest C-reactive protein levels (3.5 mg per L or higher) had a relative risk of 2.50. In women with baseline C-reactive protein levels of 1 mg per L, 1 to 3 mg per L, and more than 3 mg per L, the relative risks of developing hypertension in crude analysis were 1.00, 1.46, and 2.11, respectively. This risk was attenuated, but the pattern still held, when adjusted statistical models were applied.
The authors conclude that baseline levels of C-reactive protein are modestly but independently associated with an increased risk of hypertension. They add that this risk is associated even with patients who have very low initial systolic and diastolic blood pressures. The authors cite this finding as evidence that inflammation may play a role in the development of hypertension.
Sesso HD, et al. C-reactive protein and the risk of developing hypertension. JAMA. December 10, 2003;290:2945–51.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions